We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Protein Myomixer Essential for Muscle Formation

Protein Myomixer Essential for Muscle Formation content piece image
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

UT Southwestern Medical Center researchers discovered a small protein named Myomixer essential for the formation of skeletal muscle, findings that could eventually help treat genetic diseases such as muscular dystrophy and other myopathies. Using a technique that removes genes from cells, scientists showed that both Myomixer and Myomaker, another protein the group previously identified, must be present for muscle cells to fuse together to create muscle fibers, the building blocks of muscles. Moreover, Myomixer and Myomaker can cause other types of cells to fuse together.

“The most remarkable finding is that if you express both Myomaker and Myomixer together, they can fuse nonmuscle cells. For example, skin cells will fuse to each other or to muscle cells very efficiently in the presence of these two proteins. This ability opens the door for possible therapeutic strategies in which cells that have cargo can be fused with any other cell,” said author Dr. Eric Olson, Chairman of Molecular Biology, Co-Director of the UT Southwestern Wellstone Muscular Dystrophy Cooperative Research Center, and Director of the Hamon Center for Regenerative Science and Medicine.

“For example, if a muscle fiber is missing a gene, then another cell that carries the missing gene could be fused to the defective cell by Myomaker plus Myomixer to provide the missing gene,” explained Dr. Olson, who holds the Pogue Distinguished Chair in Research on Cardiac Birth Defects, the Robert A. Welch Distinguished Chair in Science, and the Annie and Willie Nelson Professorship in Stem Cell Research.

Myomixer and Myomaker also have implications for regenerative medicine. Skeletal muscle is the largest tissue in the body, accounting for about 40 percent of human body mass, and is the type of muscle used to move limbs. When skeletal muscle is injured, it repairs itself and the Myomixer/Myomaker combination is fundamental to that muscle repair process.

“The discovery of Myomixer, a micropeptide, provides a key component to our understanding of skeletal muscle formation and regeneration,” said Dr. Rhonda Bassel-Duby, Professor of Molecular Biology, Associate Director of the Hamon Center for Regenerative Science and Medicine, and a co-author of the study. ​

Other UT Southwestern researchers who contributed to this work are Dr. Pengpeng Bi, postdoctoral researcher; Andres Ramirez-Martinez, graduate student researcher; Dr. Hui Li, research scientist; Dr. Jessica Cannavino, postdoctoral researcher; John R. McAnally, research scientist; John M. Shelton, senior research scientist; and Dr. Efrain Sanchez-Ortiz, research associate. This research was supported by grants from the National Institutes of Health (NIH) and the Robert A. Welch Foundation.


This article has been republished from materials provided by UT Southwestern. Note: material may have been edited for length and content. For further information, please contact the cited source.